Cyclo Therapeutics Inc (CYTH)
1.38
-0.05
(-3.50%)
USD |
NASDAQ |
May 16, 16:00
1.38
0.00 (0.00%)
After-Hours: 16:59
Cyclo Therapeutics Profit Margin (Quarterly): -1.81K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.81K% |
| September 30, 2023 | -963.0% |
| June 30, 2023 | -3.96K% |
| March 31, 2023 | -3.29K% |
| December 31, 2022 | -2.67K% |
| September 30, 2022 | -939.2% |
| June 30, 2022 | -637.0% |
| March 31, 2022 | -1.42K% |
| December 31, 2021 | -477.2% |
| September 30, 2021 | -955.7% |
| June 30, 2021 | -1.51K% |
| March 31, 2021 | -1.13K% |
| December 31, 2020 | -1.84K% |
| September 30, 2020 | -645.3% |
| June 30, 2020 | -1.05K% |
| March 31, 2020 | -808.6% |
| December 31, 2019 | -1.16K% |
| September 30, 2019 | -568.5% |
| June 30, 2019 | -500.9% |
| March 31, 2019 | -862.3% |
| December 31, 2018 | -570.1% |
| September 30, 2018 | -350.7% |
| June 30, 2018 | -369.0% |
| March 31, 2018 | -410.4% |
| December 31, 2017 | -821.6% |
| Date | Value |
|---|---|
| September 30, 2017 | -262.8% |
| June 30, 2017 | -158.2% |
| March 31, 2017 | -323.7% |
| December 31, 2016 | -157.7% |
| September 30, 2016 | -580.5% |
| June 30, 2016 | -278.7% |
| March 31, 2016 | -225.7% |
| December 31, 2015 | -650.4% |
| September 30, 2015 | -318.6% |
| June 30, 2015 | -94.70% |
| March 31, 2015 | -224.2% |
| December 31, 2014 | -71.13% |
| September 30, 2014 | -57.01% |
| June 30, 2014 | -87.24% |
| March 31, 2014 | 17.30% |
| December 31, 2013 | -36.02% |
| September 30, 2013 | -56.50% |
| June 30, 2013 | 37.23% |
| March 31, 2013 | 20.58% |
| December 31, 2012 | 43.90% |
| September 30, 2012 | -29.06% |
| June 30, 2012 | -38.08% |
| March 31, 2012 | 10.36% |
| December 31, 2011 | -40.84% |
| September 30, 2011 | -21.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.96K%
Minimum
Jun 2023
-477.2%
Maximum
Dec 2021
-1.39K%
Average
-1.05K%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.99K% |
| Return on Assets | -315.4% |
| Return on Invested Capital | -3.99K% |
| Gross Profit Margin (Quarterly) | 95.02% |
| Operating Margin (Quarterly) | -1.81K% |
| Return on Net Operating Assets | -375.6% |